Posts Tagged ‘digital health technology’



David Scher on Getting Digital Health to Grapple with Reality

January 27th, 2014
Posted by

David Scher’s post was originally published on The Digital Health Corner.

At Popper and Company, we’ve written about the importance of gaining consumer—and physician—acceptance of digital health technology. In his post, digital health expert and physician David Scher points out five obstacles standing in the way of obtaining real adoption of digital health:

  • creating or integrating processes to enable the new technology’s use,
  • knowing how patients behave as customers,
  • assumptions that government funding eases acceptance,
  • developing new business models and partnerships, and
  • identifying realistic outcomes.

We believe in helping facilitate the convergence of healthcare with technology and other industries. Thus, we hope you will read David’s full post on The Digital Health Corner to learn more about his ideas.

Tags: ,
Posted in Our Views | No Comments »





Technology Access Could Lower Barriers to Clinical Trial Acceptance

August 13th, 2013
Posted by

“Research is to see what everybody else has seen, and to think what nobody else has thought.” Nobel Laureate Albert Szent-Gyorgyi no doubt would be impressed with the modern pace of medical research, but possibly concerned that we need to think about clinical trials in ways nobody else has.
 
Only 3% of people with cancer enroll in a Phase I trial, but 72% of all Americans say they would gladly volunteer on the advice of their doctor. Social media and internet tools have tremendous potential for increasing volunteer enrollment in clinical trials, but many barriers still exist. The factors keeping potential trial volunteers away have been consistent over the years: unease with trial settings, randomization and placebos; lack of understanding or discomfort with the research process; fear of drug side effects and trial protocol rules/requirements; as well as lack of awareness, a perception that trials aren’t appropriate for serious disease, and hesitation among physicians to make recommendations. Read the rest of this entry »

Tags: , , ,
Posted in Our Views | No Comments »